Patent · US Active

Methods of treating and preventing cancer drug resistance

US9925240B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2014
Grant dateMar 27, 2018
Priority date—
Expiry dateMar 6, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are combination therapies for the treatment of pathological conditions, such as cancer, using an antagonist of FGFR signaling.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.